Regent Assay formed by merger of Regent Partners LLP and Assay Corporate Finance Limited

We are pleased to announce the merger of Regent Partners LLP (“Regent”) with Assay Corporate Finance Limited (“Assay”) as of 31st March 2019. The new firm, Regent Assay Limited (“Regent Assay”), operates in the mid-market across all business sectors with strong specialist skills in TMT. It has a combined team of 22 and offices in London, Birmingham and the Thames Valley.

Regent has been providing corporate finance advice to the TMT sector since 1987. During that time, it has completed some 500 transactions, many of which have been cross border. Regent operates in the mid-market range, managing transactions with a typical deal size between £10m and £200m. Activities include both M&A and growth capital raising mandates.

Clients have included major corporations such as Atos, Bridgepoint Capital, Experian, Orange, PA Group and Sage. As an established sector specialist TMT adviser, Regent has strong research capabilities and maintains an invaluable, unique database of all European TMT M&A transactions. This has allowed it to provide detailed M&A trend and valuation analysis within geographies and market sectors over many years. Regent routinely provides insightful commentary on the TMT M&A market through publications and regular speaking slots at industry conferences.

Assay is a boutique mid-market M&A practice and is a member of IMAP, the global M&A network with offices in 67 locations and 35 countries across the world. Assay also has a consulting team who supplement the M&A team and deliver Assay’s disruptive range of proprietary consulting products, including its Equity Acceleration Plan. Recent clients have included The Cooperative Group, GKN, Royal Mail and Royal Mint. Assay has also worked with Private Equity houses such as BGF, Calculus Capital, Foresight and is a key London partner for Caple, the unsecured credit specialist.

“This merger brings to Regent greater scale and membership of IMAP, one of the largest international M&A networks. We look forward to working with our new colleagues in order to continue to build on our established success in the TMT sector.” James Calvert, Regent Partners LLP.

“The merger reflects Regent Assay’s continued focus on driving sector expertise in the UK mid-market, with the addition of a world class TMT team. Regent’s exclusive focus on TMT, its network of TMT contacts and its wealth of experience will provide Regent Assay and its IMAP partners with in-depth sector expertise, as well as impressive research, process, and deal making capabilities. We look forward to sharing our enhanced capabilities with our clients, partners and contacts over the coming months. We remain committed to delivering high quality tailored M&A advice to our clients as we move forward under the Regent Assay brand.” Ian Bussey, Assay Corporate Finance.

For further information, please contact Ian Bussey on +44 (0)7825 556662,  ibussey@assaycorpfin.com or James Calvert on +44 (0)7831 872694, jcalvert@regent.com, or alternatively log onto www.assaycorpfin.com,  www.regent.com.